Analysis of thrombotic adverse reactions of COVID-19 AstraZeneca vaccine reported to EudraVigilance database

M Tobaiqy, H Elkout, K MacLure - Vaccines, 2021 - mdpi.com
The development of safe, effective, affordable vaccines against COVID-19 remains the
cornerstone to mitigating this pandemic. Early in December 2020, multiple research groups …

Pharmacists in pharmacovigilance: can increased diagnostic opportunity in community settings translate to better vigilance?

P Rutter, D Brown, J Howard, C Randall - Drug safety, 2014 - Springer
The pharmacy profession has undergone substantial change over the last two to three
decades. Whilst medicine supply still remains a central function, pharmacist's roles and …

Pharmacovigilance insights into drug-induced cystitis: analysis of FDA data from 2004 to 2024

F Zheng, X Yang, S Li, Y Yuan, Z Wang… - Expert Opinion on …, 2024 - Taylor & Francis
Background Drug-induced cystitis (DIC) significantly impacts patient quality of life and
treatment outcomes. This study investigates the incidence and characteristics of DIC using …

Community Pharmacists' Knowledge, Attitudes and the Perceived Safety and Effectiveness of Melatonin Supplements: A Cross-Sectional Survey

M Tobaiqy, FA AlZahrani, AS Hassan, AH Alirbidi… - Pharmacy, 2023 - mdpi.com
Melatonin, which is classified as a dietary supplement by the Saudi Food and Drug
Authority, is used to manage sleep disorders. In this study, community pharmacists' …

Parental reporting of adverse drug reactions associated with attention-deficit hyperactivity disorder (ADHD) medications in children attending specialist paediatric …

M Tobaiqy, D Stewart, PJ Helms, J Williams, J Crum… - Drug safety, 2011 - Springer
Background: The development of systems to ensure appropriate and informed use of
medicines in children is a global priority. Current pharmacovigilance systems, such as the …

Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system

Y Lu, Q Xu, S Zhu - Frontiers in Pharmacology, 2024 - frontiersin.org
Background This study aims to investigate adverse drug reaction signals associated with
coagulopathies through data mining using the Adverse Event Reporting System (FAERS) of …

Investigating drug-induced urinary retention: a pharmacovigilance analysis of FDA adverse event reports from 2004 to 2024

F Zheng, F Wang, Y Yuan, Z Wang, S Li… - Expert Opinion on …, 2024 - Taylor & Francis
Background Drug-induced urinary retention (DIUR) can severely impact patient quality of life
and complicate treatment. This study investigates the incidence and characteristics of DIUR …

Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021

T Jiang, H Su, J Xu, C Li, N Zhang, Y Li… - … Advances in Drug …, 2024 - journals.sagepub.com
Background: Drug-induced interstitial lung disease (DILD) is an increasingly common cause
of morbidity and mortality. However, due to the lack of specificity, DILD detection remains an …

Community pharmacy use by children across Europe: A narrative literature review

M Blair, A Menon - Pharmacy, 2018 - mdpi.com
The use of community pharmacies across Europe has potential to alleviate the burden on
overstretched healthcare providers. Children and young people (0–18 years) account for a …

Intensive monitoring studies for assessing medicines: a systematic review

C Torre, M Cary, FC Borges, PS Ferreira… - Frontiers in …, 2019 - frontiersin.org
Introduction: Intensive monitoring (IM) is one of the methods of post-marketing active
surveillance based upon event monitoring, which has received interest in the current …